Advertisement
Table 1 Patient and tumour characteristics
| Numerical display | LN positive (n = 12) | LN negative (n = 48) | Test | P value | |
|---|---|---|---|---|---|
| Age in years | Mean (95%CI) | 45.8 (38.5–53.0) | 46.7 (43.3–50.0) | T-test | 0.732 |
| FIGO stage | |||||
| Ia2 | n (%) | 0 (0.0) | 2 (4.2) | χ 2 | 0.134 |
| Ib1 | n (%) | 6 (50.0) | 37 (77.1) | ||
| Ib2 | n (%) | 2 (16.7) | 2 (4.2) | ||
| IIa | n (%) | 4 (33.3) | 7 (14.6) | ||
| Histological subtype | |||||
| Squamous cell carcinoma | n (%) | 11 (91.7) | 29 (60.4) | χ 2 | 0.119 |
| Adenocarcinoma | n (%) | 1 (8.3) | 17 (35.4) | ||
| Adenosquamous carcinoma | n (%) | 0 (0.0) | 2 (4.2) | ||
| Lymph nodes | |||||
| Number of positive LN | Median (min-max) | 1 (1–7) | 0 (0–0) | Mann–Whitney | <0.001 |
| Number of removed LN | Median (min-max) | 28 (4–50) | 34 (18–89) | Mann–Whitney | 0.241 |
| LVSI | |||||
| Positive | n (%) | 10 (83.3) | 16 (33.3) | χ 2 | 0.005 |
| Negative | n (%) | 2 (16.7) | 32 (66.7) | ||
| Follow-up | |||||
| Follow-up (in months) | Mean (95%CI) | 61.8 (42.0–81.5) | 61.7 (49.0–66.5) | T-test | 0.997 |
| Recurrence | |||||
| Recurrence | n (%) | 3 (25.0) | 7 (14.6) | χ 2 | 0.665 |
| No recurrence | n (%) | 9 (75.0) | 41 (85.4) | ||
